Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Szukaj
A beginner’s guide to fighting off cat parasites
Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages.
Collaboration Driving Innovation
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
Research Beyond Borders overview
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Open Innovation at Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
“Rapid progress towards clinical candidates”
Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Heart murmur in dogs: symptoms and how to treat it
Monitoring your dog’s heart can save its life
Keisukes Story
Listen to Keisuke, who has heart failure, speak about the impact of his heartbeat moment.
Where to meet us
Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team.
Big hearts united to help animals in Ukraine
Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.
Performance Indicators
Performance indicators concerning Environment Health and Safety (EHS) are summarized here.
1990-2022: Wartość dzięki innowacjom
The Boehringer Ingelheim history from 1990 to 2022, with milestones
Historia (1885-1948): Nowatorskie początki
Historia Boehringer Ingelheim od rozpoczęcia działalności w 1885 roku do 1948 roku, z kamieniami milowymi i ważnymi produktami
Schizofrenia w prawdziwym życiu: historie o wyzwaniach, odporności i nadziei
Schizofrenia w prawdziwym życiu: historie o wyzwaniach, odporności i nadziei
Historia Boehringer Ingelheim w latach 1948-1990,
Historia Boehringer Ingelheim w latach 1948-1990, z kamieniami milowymi
Historia
Boehringer Ingelheim to rodzinna firma farmaceutyczna założona w 1885 r. w Niemczech przez Alberta Boehringera. Dowiedz się więcej o historii naszej firmy.
Contact us
Find all our contact information here about our BD&L team.
Supply Chain Scholarship for Cowtribe
A supply chain course we sponsored boosted the career of Latifa Saaka
Contact Us
Contact our partnering team to discuss your project and learn more about how we can work together.
Mechanistic Modeling in Biotherapeutic Drug Development
Mechanistic modeling is revolutionizing biotherapeutic drug development with the goal of getting new medicines to patients faster, more reliably and more cost-effectively.
Choroby odzwierzęce: 3 rzeczy, które warto wiedzieć
Choroby odzwierzęce: 3 rzeczy, które warto wiedzieć
XXVIII Międzynarodowy Kongres Polskiego Towarzystwa Kardiologicznego
XXVIII Międzynarodowy Kongres Polskiego Towarzystwa Kardiologicznego